Denka Co Ltd

Chart & Performance

D1W1MN

P/E

15.61

P/S

0.48

EPS

138.63

Div Yield, %

4.16%

Shrs. gr., 5y

-0.30%

Rev. gr., 5y

-1.18%

Revenues

389.26b

-4.49%

Net income

11.95b

-6.43%

CFO

36.26b

+305.32%

Dividend

Mar 28, 20250 JPY/sh

Earnings

Feb 05, 2025

Profile

Denka Company Limited manufactures and sells organic and inorganic materials to electronic materials and pharmaceuticals in Japan and internationally. The company's Electronics & Innovative Products division provides conductive agents for lithium for lithium-ion batteries, thermal materials and substrates, functional ceramics, films, and tapes. Its Life Innovation division supplies influenza vaccines; manufactures rapid diagnostic testing kits for detecting antigens of infectious diseases, such as the novel coronavirus; and delivers macromolecular sodium hyaluronate preparations. The company's Elastomers & Infrastructure Solutions division include functional elastomers, cement and special cement additives, fertilizers, agricultural corrugated pipes. Its Polymer Solutions division consist of styrene-based resins, food packaging sheets, and synthetic fiber for wigs and hairpieces, as well as poval and other chemical products. The company was formerly known as Denki Kagaku Kogyo Kabushiki Kaisha and changed its name to Denka Company Limited in October 2015. Denka Company Limited was incorporated in 1915 and is headquartered in Tokyo, Japan.

URL

https://www.denka.co.jp/

IPO date

May 16, 1949

Employees

4,198

Domiciled in

Incorporated in

Valuation

Order:

Title JPY in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title JPY in thousands, except ratios and share amounts	2024‑03	2023‑03	2022‑03	2021‑03	2020‑03	2019‑03	2018‑03	2017‑03	2016‑03	2015‑03
Income
Revenues	389,263,000 -4.49%	407,559,000 5.90%	384,849,000 8.59%
Cost of revenue	378,368,000	377,485,000	347,009,000
Unusual Expense (Income)
NOPBT	10,895,000	30,074,000	37,840,000
NOPBT Margin	2.80%	7.38%	9.83%
Operating Taxes	2,466,000	1,553,000	9,668,000
Tax Rate	22.63%	5.16%	25.55%
NOPAT	8,429,000	28,521,000	28,172,000
Net income	11,947,000 -6.43%	12,768,000 -50.91%	26,012,000 14.16%
Dividends	(7,764,000)	(12,510,000)	(11,647,000)
Dividend yield	3.84%	5.30%	3.97%
Proceeds from repurchase of equity	(150,000)	43,897,000	9,549,000
BB yield	0.07%	-18.61%	-3.26%
Debt
Debt current	64,368,000	62,729,000	61,015,000
Long-term debt	112,775,000	109,327,000	78,006,000
Deferred revenue		5,447,000	5,134,000
Other long-term liabilities	6,364,000	5,161,000	3,324,000
Net debt	89,217,000	88,317,000	54,359,000
Cash flow
Cash from operating activities	36,260,000	8,946,000	42,630,000
CAPEX	(44,679,000)	(39,840,000)	(37,954,000)
Cash from investing activities	(22,572,000)	(28,268,000)	(36,839,000)
Cash from financing activities	712,000	18,361,000	(12,341,000)
FCF	(8,228,000)	(8,593,000)	167,000
Balance
Cash	35,386,000	20,199,000	20,210,000
Long term investments	52,540,000	63,540,000	64,452,000
Excess cash	68,462,850	63,361,050	65,419,550
Stockholders' equity	275,292,000	520,739,000	512,217,000
Invested Capital	429,180,150	412,866,950	366,423,450
ROIC	2.00%	7.32%	7.98%
ROCE	2.14%	6.19%	8.48%
EV
Common stock shares outstanding	86,195	86,230	86,228
Price	2,346.50 -14.20%	2,735.00 -19.56%	3,400.00 -23.08%
Market cap	202,255,932 -14.24%	235,839,304 -19.56%	293,175,333 -23.08%
EV	300,849,932	590,171,304	613,034,333
EBITDA	37,814,000	57,114,000	61,722,000
EV/EBITDA	7.96	10.33	9.93
Interest	1,683,000	1,157,000	924,000
Interest/NOPBT	15.45%	3.85%	2.44%